US Supreme Court rejects Teva challenge to $235 million GSK award in patent dispute
Israel's Teva Pharmaceuticals and GlaxoSmithKline (GSK) have been disputing over this patent lawsuit since 2014.
Teva building in Kfar Saba(photo credit: SIVAN FARAGE)